Menu
 
Research menu
Jump to menu

Publications:  Mr Brennan Kahan

Tsui M, Rehal S, Jairath V, Kahan BC(2019). Most noninferiority trials were not designed to preserve active comparator treatment effects. J Clin Epidemiol vol. 110, 82-89.
10.1016/j.jclinepi.2019.03.003
Oakland K, Kahan BC, Guizzetti L, Martel M, Bryant RV, Brahmania M, Singh S, Nguyen NQ et al.(2019). Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clin Gastroenterol Hepatol vol. 17, (6) 1121-1129.e2.
10.1016/j.cgh.2018.09.039
Peden CJ, Stephens T, Martin G, Kahan BC, Thomson A, Rivett K, Wells D, Richardson G et al.(2019). Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial. Lancet
10.1016/S0140-6736(18)32521-2
Edwards MR, Forbes G, MacDonald N, Berdunov V, Mihaylova B, Dias P, Thomson A, Grocott MP et al.(2019). Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open vol. 9, (1) e023455-e023455.
10.1136/bmjopen-2018-023455
Sey MSL, Mohammed SB, Brahmania M, Singh S, Kahan BC, Jairath V(2019). Comparative outcomes in patients with ulcer- vs non-ulcer-related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients. Aliment Pharmacol Ther vol. 49, (5) 537-545.
10.1111/apt.15092
Greenberg L, Jairath V, Pearse R, Kahan BC(2018). Pre-specification of statistical analysis approaches in published clinical trial protocols was inadequate. J Clin Epidemiol vol. 101, 53-60.
10.1016/j.jclinepi.2018.05.023
Yelland LN, Kahan BC, Dent E, Lee KJ, Voysey M, Forbes AB, Cook JA(2018). Prevalence and reporting of recruitment, randomisation and treatment errors in clinical trials: A systematic review. Clin Trials vol. 15, (3) 278-285.
10.1177/1740774518761627
Kahan BC, Jairath V(2018). Outcome pre-specification requires sufficient detail to guard against outcome switching in clinical trials: a case study. Trials vol. 19, (1)
10.1186/s13063-018-2654-z
Kahan BC, Morris TP, Harris E, Pearse R, Hooper R, Eldridge S(2018). Re-randomization increased recruitment and provided similar treatment estimates as parallel designs in trials of febrile neutropenia. J Clin Epidemiol vol. 97, 14-19.
10.1016/j.jclinepi.2018.02.002
Leyrat C, Morgan KE, Leurent B, Kahan BC(2018). Response to: How to design and analyse cluster randomized trials with a small number of clusters? Comment on Leyrat et al. Int J Epidemiol
10.1093/ije/dyy062
Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, Harrison RN, Mustafa RA et al.(2018). Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion. N Engl J Med vol. 378, (14) 1313-1322.
10.1056/NEJMoa1716883
Leyrat C, Morgan KE, Leurent B, Kahan BC(2018). Cluster randomized trials with a small number of clusters: which analyses should be used?. Int J Epidemiol vol. 47, (1) 321-331.
10.1093/ije/dyx169
NEWTON SL, Ball E, Kahan B, Forbes G, Wright N, Cantalapiedra-Calvete C, Gibson H, Rogozinska E et al.(2018). Smartphone App Using Mindfulness Meditation for Women With Chronic Pelvic Pain (MEMPHIS): Protocol for a Randomized Feasibility Trial. Journal of Medical Internet Research vol. 7, (1)
10.2196/resprot.7720
Kelly AM, Garner SF, Foukaneli T, Godec TR, Herbert N, Kahan BC, Deary A, Bakrania L et al. (2017). The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial. Blood. vol. 130, 214-220.
10.1182/blood-2017-01-759258
Kahan BC, Feagan B, Jairath V(2017). A comparison of approaches for adjudicating outcomes in clinical trials. Trials vol. 18, (1) 266-266.
10.1186/s13063-017-1995-3
Kahan B, Jairath V (2017). A comparison of adjudication approaches for clinical trials. TRIALS. vol. 18,
Greenberg L, Jairath V, Kahan BC (2017). Do trialists adequately pre-specify their statistical analysis approach? A review and re-analysis. TRIALS. vol. 18,
Kahan B (2017). Using re-randomisation in clinical trials to increase patient recruitment. TRIALS. vol. 18,
Odutayo A, Desborough MJR, Trivella M, Stanley AJ, Dorée C, Collins GS, Hopewell S, Brunskill SJ et al.(2017). Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol vol. 2, (5) 354-360.
10.1016/S2468-1253(17)30054-7
Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, Moreno R, Pearse RM et al.(2017). Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. Intensive Care Med vol. 43, (7) 971-979.
10.1007/s00134-016-4633-8
Desborough MJR, Kahan BC, Stanworth SJ, Jairath V(2017). Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding. Hepatology vol. 65, (3) 1079-1080.
10.1002/hep.28915
Pearse RM, ABBOTT T, Haslop R, Ahmad T, Kahan BC, Filippini C, Rhodes A, Ranieri M(2017). Prevention of Respiratory Insufficiency after Surgical Management (PRISM) trial: report of the protocol for a pragmatic randomised controlled trial of Continuous Positive Airway Pressure (CPAP) to prevent respiratory complications and improve survival following major abdominal surgery. Minerva Anestesiol vol. 83, (2) 175-182.
10.23736/S0375-9393.16.11502-0
Morgan KE, Forbes AB, Keogh RH, Jairath V, Kahan BC(2017). Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome. Stat Med vol. 36, (2) 318-333.
10.1002/sim.7137
Garner SF, Furnell A, Kahan BC, Jones CI, Attwood A, Harrison P, Kelly AM, Goodall AH et al.(2017). Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time. Vox Sang vol. 112, (1) 18-24.
10.1111/vox.12468
Kahan BC(2016). Using re-randomization to increase the recruitment rate in clinical trials - an assessment of three clinical areas. Trials vol. 17, (1)
10.1186/s13063-016-1736-z
Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McKenzie JE(2016). The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials vol. 17, (1) 575-575.
10.1186/s13063-016-1685-6
McRobbie H, Hajek P, Peerbux S, Kahan BC, Eldridge S, Trépel D, Parrott S, Griffiths C et al.(2016). Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation. Health Technol Assess vol. 20, (79) 1-150.
10.3310/hta20790
Kahan BC, Forbes G, Ali Y, Jairath V, Bremner S, Harhay MO, Hooper R, Wright N et al.(2016). Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study. Trials vol. 17, (1) 438-438.
10.1186/s13063-016-1571-2
Kahan BC, Doré CJ, Murphy MF, Jairath V(2016). Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. J Clin Epidemiol vol. 77, 38-43.
10.1016/j.jclinepi.2016.05.008
Cardillo G, Bintcliffe OJ, Carleo F, Carbone L, Di Martino M, Kahan BC, Maskell NA(2016). Primary spontaneous pneumothorax: a cohort study of VATS with talc poudrage. Thorax vol. 71, (9) 847-853.
10.1136/thoraxjnl-2015-207976
Cho G, Anie KA, Buckton J, Kiilu P, Layton M, Alexander L, Hemmaway C, Sutton D et al.(2016). SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt. BMJ Open vol. 6, (6) e011276-e011276.
10.1136/bmjopen-2016-011276
Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McKenzie JE(2016). Appropriate statistical methods were infrequently used in cluster-randomized crossover trials. Journal of Clinical Epidemiology vol. 74, Article C, 40-50.
10.1016/j.jclinepi.2015.11.013
Eldridge SM, Costelloe CE, Kahan BC, Lancaster GA, Kerry SM(2016). How big should the pilot study for my cluster randomised trial be?. Stat Methods Med Res vol. 25, (3) 1039-1056.
10.1177/0962280215588242
Taylor SJC, Carnes D, Homer K, Kahan BC, Hounsome N, Eldridge S, Spencer A, Pincus T et al.(2016). Novel Three-Day, Community-Based, Nonpharmacological Group Intervention for Chronic Musculoskeletal Pain (COPERS): A Randomised Clinical Trial. PLoS Med vol. 13, (6)
10.1371/journal.pmed.1002040
Kahan BC, Rushton H, Morris TP, Daniel RM(2016). A comparison of methods to adjust for continuous covariates in the analysis of randomised trials. BMC Medical Research Methodology vol. 16, (1)
10.1186/s12874-016-0141-3
Kahan BC, Harhay MO(2015). Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs. Journal of Clinical Epidemiology vol. 68, (12) 1504-1511.
10.1016/j.jclinepi.2015.03.016
Kahan BC, Harhay MO(2015). Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs. J Clin Epidemiol vol. 68, (12) 1504-1511.
10.1016/j.jclinepi.2015.03.016
Kahan B, Jairath V (2015). Can we reduce bias in open-label trials when blinded outcome assessment is not possible? An example from the trigger trial. TRIALS. vol. 16,
10.1186/1745-6215-16-S2-O71
Kahan B, Forbes A, Dore C, Morris T (2015). Using re-randomisation to improve patient recruitment and increase statistical power in clinical trials. TRIALS. vol. 16,
10.1186/1745-6215-16-S2-P219
Kahan BC, Forbes AB, Doré CJ, Morris TP(2015). A re-randomisation design for clinical trials. BMC Med Res Methodol vol. 15,
10.1186/s12874-015-0082-2
Kahan BC, Rehal S, Cro S(2015). Risk of selection bias in randomised trials. Trials vol. 16,
10.1186/s13063-015-0920-x
Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM et al.(2015). Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet vol. 386, (9989) 137-144.
10.1016/S0140-6736(14)61999-1
Bhatnagar R, Kahan BC, Morley AJ, Keenan EK, Miller RF, Rahman NM, Maskell NA(2015). The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial. Trials vol. 16,
10.1186/s13063-015-0563-y
Clive AO, Hooper CE, Edey AJ, Morley AJ, Zahan-Evans N, Hall D, Lyburn I, White P et al.(2015). A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study. PLoS One vol. 10, (3)
10.1371/journal.pone.0118569
Kahan BC, Rehal S, Cro S(2015). Blinded Outcome Assessment Was Infrequently Used and Poorly Reported in Open Trials. PLoS One vol. 10, (6)
10.1371/journal.pone.0131926
Clive AO, Kahan BC, Maskell NA(2014). Authors' response to Murray et al. Thorax vol. 69, (12) 1144-1145.
10.1136/thoraxjnl-2014-206247
Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC et al.(2014). Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score. Thorax vol. 69, (12) 1098-1104.
10.1136/thoraxjnl-2014-205285
Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC et al.(2014). Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax vol. 69, (12) 1098-1104.
10.1136/thoraxjnl-2014-205285
Bhatnagar R, Laskawiec-Szkonter M, Piotrowska HEG, Kahan BC, Hooper CE, Davies HE, Harvey JE, Miller RF et al.(2014). Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial. BMJ Open vol. 4, (11)
10.1136/bmjopen-2014-007045
Kahan BC, Cro S, Doré CJ, Bratton DJ, Rehal S, Maskell NA, Rahman N, Jairath V(2014). Reducing bias in open-label trials where blinded outcome assessment is not feasible: Strategies from two randomised trials. Trials
10.1186/1745-6215-15-456
Kahan BC, Cro S, Doré CJ, Bratton DJ, Rehal S, Maskell NA, Rahman N, Jairath V(2014). Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. Trials vol. 15,
10.1186/1745-6215-15-456
Jairath V, Thompson J, Kahan BC, Daniel R, Hearnshaw SA, Travis SPL, Murphy MF, Palmer KR et al.(2014). Poor outcomes in hospitalized patients with gastrointestinal bleeding: impact of baseline risk, bleeding severity, and process of care. The American journal of gastroenterology vol. 109, (10) 1603-1612.
10.1038/ajg.2014.263
Jairath V, Thompson J, Kahan BC, Daniel R, Hearnshaw SA, Travis SPL, Murphy MF, Palmer KR et al.(2014). Poor outcomes in hospitalized patients with gastrointestinal bleeding: impact of baseline risk, bleeding severity, and process of care. Am J Gastroenterol vol. 109, (10) 1603-1612.
10.1038/ajg.2014.263
Eldridge S, Spenser A, Pincus T, Rahman A, Bremner SA, Underwood MR, Taylor SJC, Carnes D et al.(2014). EFFECTIVENESS AND COST-UTILITY OF A GROUP SELF-MANAGEMENT SUPPORT INTERVENTION (COPERS) FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN: A RANDOMISED CONTROLLED TRIAL. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH vol. 68, A13-A14.
10.1136/jech-2014-204726.24
Gray A, Jairath V, Kahan B, Dore C, Palmer K, Travis S, Logan R, Walsh T et al.(2014). Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (trigger): pragmatic, cluster randomised, feasibility trial. Emerg Med J vol. 31, (9)
10.1136/emermed-2014-204221.8
Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McDonald S, McKenzie JE(2014). The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review. Syst Rev vol. 3,
10.1186/2046-4053-3-86
Jairath V, Kahan B, Gray A, Dore C, Palmer K, Travis S, Logan R, Walsh T et al.(2014). PTU-184 Restrictive Versus Liberal Blood Transfusion For Acute Upper Gastrointestinal Bleeding: Cluster Randomised Feasibility Trial. Gut vol. 63 Suppl 1, A119-A120.
10.1136/gutjnl-2014-307263.258
Kahan BC, Morris TP(2014). The consequences of randomizing schools rather than children. J Sch Health vol. 84, (6)
10.1111/josh.12155
Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, Travis S, Murphy M et al.(2014). Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis vol. 46, (5) 419-426.
10.1016/j.dld.2013.12.010
Kahan BC, Jairath V, Doré CJ, Morris TP(2014). The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials vol. 15,
10.1186/1745-6215-15-139
Kahan BC, Diaz-Ordaz K, Homer K, Carnes D, Underwood M, Taylor SJC, Bremner SA, Eldridge S(2014). Coping with Persistent Pain, Effectiveness Research into Self-management (COPERS): Statistical analysis plan for a randomised controlled trial. Trials vol. 15, (1)
10.1186/1745-6215-15-59
Kahan BC, Diaz-Ordaz K, Homer K, Carnes D, Underwood M, Taylor SJ, Bremner SA, Eldridge S(2014). Coping with persistent pain, effectiveness research into self-management (COPERS): statistical analysis plan for a randomised controlled trial. Trials vol. 15,
10.1186/1745-6215-15-59
Kahan BC(2014). Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?. BMC Med Res Methodol vol. 14,
10.1186/1471-2288-14-20
Morris TP, Kahan BC, White IR(2014). Choosing sensitivity analyses for randomised trials: principles. BMC Med Res Methodol vol. 14,
10.1186/1471-2288-14-11
Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, Travis S, Murphy M et al.(2014). Acute variceal haemorrhage in the United Kingdom: Patient characteristics, management and outcomes in a nationwide audit. Digestive and Liver Disease vol. 46, (5) 419-426.
10.1016/j.dld.2013.12.010
Kahan BC(2013). Bias in randomised factorial trials. Statistics in Medicine vol. 32, (26) 4540-4549.
10.1002/sim.5869
Kahan BC(2013). Bias in randomised factorial trials. Stat Med vol. 32, (26) 4540-4549.
10.1002/sim.5869
Kahan BC, Morris TP(2013). Adjusting for multiple prognostic factors in the analysis of randomised trials. BMC Med Res Methodol vol. 13,
10.1186/1471-2288-13-99
Kahan BC, Jairath V, Murphy MF, Doré CJ(2013). Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials vol. 14,
10.1186/1745-6215-14-206
Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, Dyer C, Stokes EA, Llewelyn C et al.(2013). restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: Rationale and protocol for a cluster randomized feasibility trial. Transfusion Medicine Reviews vol. 27, (3) 146-153.
10.1016/j.tmrv.2013.04.001
Jairath V, Kahan BC, Stanworth SJ, Logan RFA, Hearnshaw SA, Travis SPL, Palmer KR, Murphy MF(2013). Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Transfusion vol. 53, (5) 1069-1076.
10.1111/j.1537-2995.2012.03849.x
Kahan BC, Morris TP(2013). Assessing potential sources of clustering in individually randomised trials. BMC Med Res Methodol vol. 13,
10.1186/1471-2288-13-58
Kahan BC, Morris TP(2013). Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?. Stat Med vol. 32, (7) 1136-1149.
10.1002/sim.5667
Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C et al.(2013). A no-prophylaxis platelet-transfusion strategy for hematologic cancers. New England Journal of Medicine vol. 368, (19) 1771-1780.
10.1056/NEJMoa1212772
Hooper CE, Morley AJ, Virgo P, Harvey JE, Kahan B, Maskell NA(2013). A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. European Respiratory Journal vol. 41, (1) 18-24.
10.1183/09031936.00148211
Jairath V, Kahan BC, Logan RFA, Hearnshaw SA, Dore CJ, Travis SPL, Murphy MF, Palmer KR(2012). National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding. BRITISH JOURNAL OF SURGERY vol. 99, (12) 1672-1680.
10.1002/bjs.8932
Stanworth SJ, Estcourt L, Powter G, Kahan BC, Dyer C, Bakrania L, Llewelyn C, Choo L et al. (2012). The Effect of a No-Prophylactic Versus Prophylactic Platelet Transfusion Strategy On Bleeding in Patients with Hematological Malignancies and Severe Thrombocytopenia (TOPPS trial). A Randomized Controlled, Non-Inferiority Trial. BLOOD. vol. 120,
Jairath V, Kahan BC, Logan RFA, Hearnshaw SA, Doré CJ, Travis SPL, Murphy MF, Palmer KR et al.(2012). Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: Results from a nationwide study. Endoskopie Heute vol. 25, (3) 196-204.
10.1055/s-0032-1325412
Muthukumar P, Venkatesh V, Curley A, Kahan BC, Choo L, Ballard S, Clarke P, Watts T et al.(2012). Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. TRANSFUSION MEDICINE vol. 22, (5) 338-343.
10.1111/j.1365-3148.2012.01171.x
Bratton DJ, Williams HC, Kahan BC, Phillips PPJ, Nunn AJ(2012). When inferiority meets non-inferiority: implications for interim analyses. Clin Trials vol. 9, (5) 605-609.
10.1177/1740774512453220
Kahan BC, Morris TP(2012). Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ vol. 345,
10.1136/bmj.e5840
Jairath V, Kahan BC, Logan RFA, Hearnshaw SA, Dore CJ, Travis SPL, Murphy MF, Palmer KR(2012). Outcomes Following Acute Nonvariceal Upper Gastrointestinal Bleeding in Relation to Time to Endoscopy: Results from a Nationwide Study. ENDOSKOPIE HEUTE vol. 25, (3) 196-204.
10.1055/s-0032-1325412
Massey E, Harding K, Kahan BC, Llewelyn C, Wynn R, Moppett J, Robinson SP, Green A et al.(2012). The granulocytes in neutropenia 1 (GIN 1) study: A safety study of granulocytes collected from whole blood and stored in additive solution and plasma. Transfusion Medicine vol. 22, (4) 277-284.
10.1111/j.1365-3148.2012.01152.x
Jairath V, Kahan BC, Logan RFA, Hearnshaw SA, Doré CJ, Travis SPL, Murphy MF, Palmer KR(2012). Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: Results from a nationwide study. Endoscopy vol. 44, (8) 723-730.
10.1055/s-0032-1309736
Jairath V, Kahan B, Logan R, Hearnshaw S, Travis S, Murphy M, Palmer K(2012). PREVALENCE, MANAGEMENT AND OUTCOMES OF PATIENTS WITH COAGULOPATHY FOLLOWING ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING. GUT vol. 61, A371-A371.
10.1136/gutjnl-2012-302514d.184
Kahan BC(2012). Rank minimization with a two-step analysis should not replace randomization in clinical trials. JOURNAL OF CLINICAL EPIDEMIOLOGY vol. 65, (7) 808-809.
10.1016/j.jclinepi.2012.02.002
Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, Davies CWH, Grayez J et al.(2012). Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion The TIME2 Randomized Controlled Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION vol. 307, (22) 2383-2389.
10.1001/jama.2012.5535
Kahan BC, Morris TP(2012). Improper analysis of trials randomised using stratified blocks or minimisation. STATISTICS IN MEDICINE vol. 31, (4) 328-340.
10.1002/sim.4431
Rahman NM, Kahan BC, Miller R, Maskell NA (2011). RAPID SCORE: THE DEVELOPMENT OF A VALIDATED CLINICAL SCORE IN PLEURAL INFECTION, TO IDENTIFY AT PRESENTATION THOSE AT RISK OF POOR OUTCOME. THORAX. vol. 66, A29-A30.
10.1136/thoraxjnl-2011-201054b.61
Barroso F, Allard S, Kahan BC, Connolly C, Smethurst H, Choo L, Khan K, Stanworth S(2011). Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol vol. 159, (1) 99-105.
10.1016/j.ejogrb.2011.07.041
Jairath V, Kahan BC, Logan RFA, Hearnshaw SA, Travis SPL, Murphy MF, Palmer KR(2011). Mortality from acute upper gastrointestinal bleeding in the United Kingdom: Does it display a weekend effect. American Journal of Gastroenterology vol. 106, (9) 1621-1628.
10.1038/ajg.2011.172
Jairath V, Kahan BC, Logan RFA, Travis SPL, Palmer KR, Murphy MF(2011). Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians. TRANSFUSION vol. 51, (9) 1940-1948.
10.1111/j.1537-2995.2011.03119.x
Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CWH et al.(2011). Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. NEW ENGLAND JOURNAL OF MEDICINE vol. 365, (6) 518-526.
10.1056/NEJMoa1012740
Jairath V, Logan R, Hearnshaw S, Kahan B, Travis S, Murphy M, Palmer K (2011). OUTCOMES FOLLOWING ACUTE VARICEAL BLEEDING IN THE 2007 UK NATIONAL AUDIT. GUT. vol. 60, A235-A235.
10.1136/gut.2011.239301.496
Jairath V, Kahan B, Logan R, Palmer K, Travis S, Murphy M (2011). RED CELL TRANSFUSION PRACTICE IN PATIENTS PRESENTING WITH ACUTE UPPER GASTROINTESTINAL BLEEDING- A SURVEY OF 815 CLINICIANS. GUT. vol. 60, A103-A103.
10.1136/gut.2011.239301.215
Jairath V, Kahan B, Dore C, Meredith S, Lweleyn C, Hearnshaw S, Walsh T, Logan R et al. (2011). UNCERTAINTY IN TRANSFUSION PRACTICE FOR ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGIB): IMPLICATIONS FOR CLINICAL TRIAL DESIGN. GUT. vol. 60,
10.1136/gut.2011.239301.214
Jairath V, Logan R, Hearnshaw S, Kahan B, Travis S, Murphy M, Palmer K (2011). WHAT ROLE DOES SURGERY PLAY IN THE MODERN DAY MANAGEMENT OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING?. GUT. vol. 60,
10.1136/gut.2011.239301.216
Return to top